Skip to main content
. 2019 Jan 7;132(2):161–170. doi: 10.1097/CM9.0000000000000054

Figure 4.

Figure 4

Combination of DNMT3A/3B overexpression with ESR1/PGR low expression and/or hypermethylation indicated poor prognosis in endometrial cancers. DNMT3A/3B: DNA (cytosine-5)-methyltransferase 3A/3B; ESR1: Estrogen receptor 1; PGR: Progesterone receptor.